España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Madrigal Pharmaceuticals
MDGL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$285.89
-7.75
-2.64%
Pre-Market: Jan 17, 6:48 PM EDT
Get Report
Comment
Madrigal Pharmaceuticals (MDGL) Forecast
News
Earnings
Madrigal Pharmaceuticals (MDGL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock
Madrigal Pharmaceuticals Stock (NASDAQ: MDGL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 20, 2025
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Friday, January 17, 2025
Watching Madrigal Pharmaceuticals; Shares Mov...
Benzinga Newsdesk
Tuesday, January 14, 2025
HC Wainwright & Co. Maintains Buy on Madrigal...
Benzinga Newsdesk
Monday, January 13, 2025
Madrigal Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Madrigal Pharmaceuticals Reports Preliminary ...
Benzinga Newsdesk
Friday, January 10, 2025
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, November 25, 2024
Top 3 Health Care Stocks That May Dip This Month
Avi Kapoor
Wednesday, November 20, 2024
Cantor Fitzgerald Reiterates Neutral on Madri...
Benzinga Newsdesk
Friday, November 15, 2024
Watching Madrigal Pharmaceuticals; Traders Ci...
Benzinga Newsdesk
Tuesday, November 05, 2024
B. Riley Securities Maintains Neutral on Madr...
Benzinga Newsdesk
Monday, November 04, 2024
Check Out What Whales Are Doing With MDGL
Benzinga Insights
Sunday, November 03, 2024
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Lekha Gupta
Friday, November 01, 2024
Madrigal Pharmaceuticals shares are trading h...
Benzinga Newsdesk
UBS Maintains Buy on Madrigal Pharmaceuticals...
Benzinga Newsdesk
Thursday, October 31, 2024
Madrigal Pharmaceuticals shares are trading h...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Madrigal Pharmaceuticals Q3 2024 GAAP EPS $(4...
Benzinga Newsdesk
Wednesday, October 30, 2024
Earnings Preview For Madrigal Pharmaceuticals
Benzinga Insights
Madrigal Pharmaceuticals To Present Multiple ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Oppenheimer Maintains Outperform on Madrigal ...
Benzinga Newsdesk
Tuesday, October 22, 2024
HC Wainwright & Co. Reiterates Buy on Madriga...
Benzinga Newsdesk
Monday, October 21, 2024
Madrigal Pharmaceuticals Completes Enrollment...
Benzinga Newsdesk
Friday, October 11, 2024
Cantor Fitzgerald Reiterates Neutral on Madri...
Benzinga Newsdesk
Monday, September 30, 2024
Madrigal Pharmaceuticals Announces Publicatio...
Benzinga Newsdesk
Friday, August 23, 2024
Viking Rises 25% in a Month: Should You Buy or Wait?
Zacks
Monday, August 12, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, August 08, 2024
Citigroup Maintains Buy on Madrigal Pharmaceu...
Benzinga Newsdesk
Evercore ISI Group Maintains Outperform on Ma...
Benzinga Newsdesk
Wednesday, August 07, 2024
Madrigal Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Check Out What Whales Are Doing With MDGL
Benzinga Insights
Madrigal Pharmaceuticals Q2 2024 GAAP EPS $(7...
Benzinga Newsdesk
Tuesday, July 23, 2024
Cantor Fitzgerald Reiterates Neutral on Madri...
Benzinga Newsdesk
Tuesday, July 16, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Friday, June 28, 2024
Cantor Fitzgerald Initiates Coverage On Madri...
Benzinga Newsdesk
Wednesday, June 12, 2024
Madrigal Pharmaceuticals's Options Frenzy: What You Need to Know
Benzinga Insights
Tuesday, June 11, 2024
Madrigal Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Madrigal...
Benzinga Newsdesk
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, June 06, 2024
Madrigal Pharmaceuticals Announces New Analys...
Benzinga Newsdesk
Wednesday, June 05, 2024
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Vandana Singh
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Friday, May 10, 2024
B. Riley Securities Maintains Neutral on Madr...
Benzinga Newsdesk
Wednesday, May 08, 2024
HC Wainwright & Co. Maintains Buy on Madrigal...
Benzinga Newsdesk
Citigroup Maintains Buy on Madrigal Pharmaceu...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Spotlight on Madrigal Pharmaceuticals: Analyzing the Surge in Options Activity
Benzinga Insights
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Madrigal Pharmaceuticals Q1 2024 GAAP EPS $(7...
Benzinga Newsdesk
Friday, May 03, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
